Director

• Engage key opinion leaders and healthcare systems to discuss evidence supporting blood-based Colorectal Cancer (CRC) screening.
• Partner with healthcare system leaders to support clinical implementation and outcomes evaluation.
• Organize and participate in scientific meetings and educational events with key opinion leaders (KOLs).
• Collaborate with investigators on data collection and study design related to Guardant Health screening assays.
• Translate research findings into actionable insights through publications and presentations.
• Contribute actively within the broader Medical Affairs organization.

Director, Clinical Value & Access – Screening

Business Director – Emerging Payments Strategy, Analytics

Director of Payer Relations, Contracting

Franchisee, Fractional C-Suite, Part-Time Director

Associate Director, Clinical Pharmacology Lead

Patient Access Director, Primary Care